Skip to content

Clinical trials

Phase 3 Lymphoma, Large B-Cell, Diffuse trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Country / region: Poland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20101
20113
20121
20132
20151
20161
20171
20203
20213
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting10
Completed8
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Genmab3
Incyte Corporation2
Janssen Research & Development, LLC2
Pfizer2
ADC Therapeutics S.A.1
Acerta Pharma BV1
CTI BioPharma1
GlaxoSmithKline1
Mabion SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse24
Lymphoma6
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell3
Neoplasms3
Recurrence3
Lymphoma, Follicular2
Bronchiolitis Obliterans Syndrome1
Hematologic Neoplasms1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.